Shang Hai Zheng Quan Bao·2025-12-24 20:15Core Viewpoint - The company has announced its expected daily related transactions for the year 2026, which will follow fair and open principles, ensuring that transaction prices are aligned with market rates and do not lead to significant dependence on related parties [1][2]. Group 1: Daily Related Transactions Overview - The board of directors approved the expected daily related transactions for 2026 with a unanimous vote, and the proposal does not require shareholder meeting approval [2]. - The independent directors conducted a special meeting to review the related transactions and expressed prior approval [2][9]. Group 2: Previous Related Transactions - In 2025, the company estimated related transactions to be 166.6 million yuan, while the actual transactions from January to November 2025 amounted to 102.0528 million yuan, indicating that the actual amount will not exceed the estimated figure [3]. Group 3: Expected Amount and Categories for 2026 - The company anticipates a total of 30 million yuan in various daily related transactions for 2026, with the current agreement with Alibaba Group's Hema set to expire on March 31, 2026, and will not be renewed [4][6]. Group 4: Related Party Information - Alibaba Group Holding Limited is identified as a major related party, being one of the largest retail entities globally and controlling significant business operations in China [5]. - The relationship with Alibaba is established through its subsidiary, which is considered a related transaction due to its ownership structure [5][9]. Group 5: Transaction Policy and Impact - The company ensures that all related transactions are conducted based on fair and open principles, with prices reflecting market conditions [7]. - These transactions are deemed necessary for the company's operational needs and are not expected to adversely affect its financial status or independence [8].